December 22, 2021
MedMira Announces VYRA™ CoV2Flu and Additional Regulatory Opportunities
VYRA™ CoV2Flu Rapid Antigen Rapid Test. VYRA™ CoV2Flu Rapid Antigen Rapid Test. HALIFAX, Nova Scotia, Dec. 21, 2021 (GLOBE NEWSWIRE)…
Pharmaceuticals, Biotechnology and Life Sciences
VYRA™ CoV2Flu Rapid Antigen Rapid Test. VYRA™ CoV2Flu Rapid Antigen Rapid Test. HALIFAX, Nova Scotia, Dec. 21, 2021 (GLOBE NEWSWIRE)…
MELBOURNE, Australia, Dec. 22, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it…
SAN DIEGO, Dec. 21, 2021 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage company focused on developing potential first-in-class…
CALGARY, Alberta, Dec. 21, 2021 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX…
DUBLIN, Ireland and FORT WASHINGTON, Pa., Dec. 21, 2021 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company…
SOUTH SAN FRANCISCO, Calif., Dec. 21, 2021 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company…
PRINCETON, N.J., Dec. 21, 2021 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), a commercial-stage biopharmaceutical company focused on…
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code…
Saint Herblain (France), December 21, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced…
Endorsement Applies to: Tauri-Gum™ Product Line New York, NY, Dec. 21, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB:…